Cited by 297Fatty Acid Research and HealthDementia and Cognitive Impairment ResearchNutritional Studies and Diet

Effect of 2-y n−3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

Open access
Dangour, Alan D, Allen, Elizabeth, Elbourne, Diana, Fasey, Nicky, Fletcher, Astrid E, Hardy, Pollyanna, Holder, Graham E, Knight, Rosemary +3 more·2010·The American Journal of Clinical Nutrition

Abstract

Background Increased consumption of n-3 (omega-3) long-chain polyunsaturated fatty acids (LC PUFAs), especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may maintain cognitive function in later life.Objective We tested the hypothesis that n-3 LC PUFA supplementation would benefit cognitive function in cognitively healthy older people.Design At total of 867 cognitively healthy adults, aged 70-79 y, from 20 general practices in England and Wales were randomly assigned into a double-blind controlled trial of daily capsules providing 200 mg EPA plus 500 mg DHA or olive oil for 24 mo. Treatment-allocation codes were obtained from a central computerized randomization service. Trained research nurses administered a battery of cognitive tests, including the primary outcome, the California Verbal Learning Test (CVLT), at baseline and 24 mo. Intention-to-treat analysis of covariance, with adjustment for baseline cognitive scores, age, sex, and age at leaving full-time education, included 748 (86%) individuals who completed the study.Results The mean age of participants was 75 y; 55% of the participants were men. Withdrawals and deaths were similar in active (n = 49 and n = 9, respectively) and placebo (n = 53 and n = 8, respectively) arms. Mean (+/-SD) serum EPA and DHA concentrations were significantly higher in the active arm than in the placebo arm at 24 mo (49.9 +/- 2.7 mg EPA/L in the active arm compared with 39.1 +/- 3.1 mg EPA/L in the placebo arm; 95.6 +/- 3.1 mg DHA/L in the active arm compared with 70.7 +/- 2.9 mg DHA/L in the placebo arm). There was no change in cognitive function scores over 24 mo, and intention-to-treat analysis showed no significant differences between trial arms at 24 mo in the CVLT or any secondary cognitive outcome.Conclusions Cognitive function did not decline in either study arm over 24 mo. The lack of decline in the control arm and the relatively short intervention period may have limited our ability to detect any potential beneficial effect of fish oil on cognitive function in this study. The Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) Study was registered at www.controlled-trials.com as ISRCTN 72331636.

Integrity signals

Registry

Crossref · 10.3945/ajcn.2009.29121

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a UK trial, 748 cognitively healthy adults aged 70-79 years receiving 500 mg DHA and 200 mg EPA or placebo daily for 24 months showed no significant difference in cognitive function between groups.

    “In a trial in the United Kingdom, 748 cognitively healthy adults aged 70–79 years received either 500 mg DHA and 200 mg EPA or a placebo daily for 24 months [83]. Cognitive function did not differ significantly between the 2 groups, although cognitive function did not decline in either group.”

Cites

Flagged first, then by citations

2 of the 50 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., & Uauy, R.
Affiliations
London School of Hygiene & Tropical Medicine (GB)
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2010-06
Volume
91
Issue
6
Pages
1725-1732
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2168895330
Cited by
296
References
50
Citations by year
2026: 7 · 2025: 11 · 2024: 4 · 2023: 11 · 2022: 12 · 2021: 15 · 2020: 26 · 2019: 18 · 2018: 23 · 2017: 14 · 2016: 21 · 2015: 35 · 2014: 19 · 2013: 22 · 2012: 23
FWCI
24.31
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
acids, omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, fish oil supplementation, cognitive function, older adults, cognitive decline, verbal learning, olive oil placebo, cognitive aging, recall and recognition, attention and processing speed, executive function, visuospatial ability, psychomotor speed
MeSH terms
Aged, Cognition, Double-Blind Method, Female, Humans, Male, Neuropsychological Tests, Patient Compliance, Fatty Acids, Omega-3, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review